Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analytic population is no longer the observed population-authors' reply
Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analytic population is no longer the observed population-authors' reply. // The Lancet Regional Health - Europe. – URL: https://www.sciencedirect.com/science/article/pii/S2666776226003455?dgcid=rss_sd_all
Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analytic population is no longer the observed population-authors' reply. The Lancet Regional Health - Europe. https://www.sciencedirect.com/science/article/pii/S2666776226003455?dgcid=rss_sd_all
“Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analytic population is no longer the observed population-authors' reply.” The Lancet Regional Health - Europe.
@article{article69290,
title = {Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analytic population is no longer the observed population-authors' reply},
journal = {The Lancet Regional Health - Europe},
url = {https://www.sciencedirect.com/science/article/pii/S2666776226003455?dgcid=rss_sd_all}
}
Abstract Aim Discretionary foods and beverages contribute to poor diet quality and chronic disease. In Australia, intake exceeds dietary guideline recommendations and is unlikely to improve without substantial intervention. We examined...
ABSTRACT Background Ultra‐processed foods (UPFs) are a leading contributor to diet‐related chronic disease and socio‐ecological harm. Despite increasing recognition of these impacts, regulatory responses remain fragmented, focused on...